Callahan Advisors LLC Has $11.14 Million Holdings in UnitedHealth Group Incorporated (UNH)

Callahan Advisors LLC lessened its holdings in UnitedHealth Group Incorporated (NYSE:UNH) by 2.3% during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 56,856 shares of the healthcare conglomerate’s stock after selling 1,334 shares during the period. UnitedHealth Group accounts for approximately 2.3% of Callahan Advisors LLC’s portfolio, making the stock its 8th largest holding. Callahan Advisors LLC’s holdings in UnitedHealth Group were worth $11,135,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also made changes to their positions in UNH. Harbour Capital Advisors LLC raised its position in shares of UnitedHealth Group by 18,383.4% in the second quarter. Harbour Capital Advisors LLC now owns 2,516,706 shares of the healthcare conglomerate’s stock valued at $13,573,000 after buying an additional 2,503,090 shares during the last quarter. Janus Henderson Group PLC raised its position in shares of UnitedHealth Group by 1,820.1% in the second quarter. Janus Henderson Group PLC now owns 2,388,641 shares of the healthcare conglomerate’s stock valued at $442,896,000 after buying an additional 2,264,242 shares during the last quarter. Vanguard Group Inc. raised its position in shares of UnitedHealth Group by 2.5% in the second quarter. Vanguard Group Inc. now owns 64,578,618 shares of the healthcare conglomerate’s stock valued at $11,974,168,000 after buying an additional 1,588,516 shares during the last quarter. Parametric Portfolio Associates LLC raised its position in shares of UnitedHealth Group by 77.3% in the second quarter. Parametric Portfolio Associates LLC now owns 3,584,134 shares of the healthcare conglomerate’s stock valued at $664,570,000 after buying an additional 1,562,661 shares during the last quarter. Finally, Jennison Associates LLC raised its position in shares of UnitedHealth Group by 180.4% in the second quarter. Jennison Associates LLC now owns 2,252,507 shares of the healthcare conglomerate’s stock valued at $417,660,000 after buying an additional 1,449,130 shares during the last quarter. 85.97% of the stock is currently owned by institutional investors.

In other news, insider Thomas E. Roos sold 975 shares of the stock in a transaction on Thursday, October 19th. The shares were sold at an average price of $205.47, for a total value of $200,333.25. Following the completion of the sale, the insider now owns 24,630 shares of the company’s stock, valued at $5,060,726.10. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director Kenneth Irwin Shine sold 457 shares of the stock in a transaction on Tuesday, November 14th. The stock was sold at an average price of $211.03, for a total transaction of $96,440.71. The disclosure for this sale can be found here. Insiders have sold 34,630 shares of company stock valued at $7,669,416 in the last ninety days. 0.89% of the stock is currently owned by company insiders.

A number of equities analysts have recently weighed in on the stock. Zacks Investment Research lowered shares of UnitedHealth Group from a “buy” rating to a “hold” rating in a research report on Tuesday, September 26th. Oppenheimer boosted their price objective on shares of UnitedHealth Group from $215.00 to $205.00 and gave the company an “outperform” rating in a research report on Wednesday, October 18th. Cantor Fitzgerald reissued a “buy” rating and issued a $208.00 price objective on shares of UnitedHealth Group in a research report on Tuesday, October 17th. Raymond James Financial reissued a “buy” rating on shares of UnitedHealth Group in a research report on Wednesday, December 6th. Finally, Morgan Stanley boosted their price objective on shares of UnitedHealth Group from $215.00 to $235.00 and gave the company an “overweight” rating in a research report on Wednesday, October 18th. Three research analysts have rated the stock with a hold rating and twenty-four have given a buy rating to the company. UnitedHealth Group presently has an average rating of “Buy” and an average target price of $224.56.

UnitedHealth Group Incorporated (NYSE:UNH) opened at $220.00 on Tuesday. UnitedHealth Group Incorporated has a 52-week low of $156.09 and a 52-week high of $231.77. The company has a debt-to-equity ratio of 0.52, a quick ratio of 0.70 and a current ratio of 0.70. The company has a market cap of $211,090.00, a P/E ratio of 25.00, a P/E/G ratio of 1.65 and a beta of 0.66.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings results on Tuesday, October 17th. The healthcare conglomerate reported $2.66 EPS for the quarter, topping the consensus estimate of $2.57 by $0.09. UnitedHealth Group had a net margin of 4.50% and a return on equity of 21.52%. The firm had revenue of $50.32 billion during the quarter, compared to analyst estimates of $50.38 billion. During the same quarter in the prior year, the business posted $2.17 earnings per share. UnitedHealth Group’s revenue for the quarter was up 8.7% compared to the same quarter last year. equities research analysts expect that UnitedHealth Group Incorporated will post 9.99 EPS for the current fiscal year.

The business also recently declared a quarterly dividend, which was paid on Tuesday, December 12th. Investors of record on Friday, December 1st were given a dividend of $0.75 per share. This represents a $3.00 annualized dividend and a yield of 1.36%. The ex-dividend date was Thursday, November 30th. UnitedHealth Group’s dividend payout ratio (DPR) is 34.09%.

ILLEGAL ACTIVITY WARNING: “Callahan Advisors LLC Has $11.14 Million Holdings in UnitedHealth Group Incorporated (UNH)” was originally reported by Community Financial News and is the sole property of of Community Financial News. If you are accessing this story on another publication, it was copied illegally and republished in violation of United States and international copyright & trademark laws. The original version of this story can be accessed at https://www.com-unik.info/2017/12/26/callahan-advisors-llc-has-11-14-million-holdings-in-unitedhealth-group-incorporated-unh.html.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit